Introduction: Severe cases of COVID-19 are associated with hypoxemic respiratory failure, acute respiratory distress syndrome (ARDS), septic shock, cardiac dysfunction, elevation in multiple inflammatory cytokines, thrombo embolic disease, and/or exacerbation of underlying co morbidities. In addition to pulmonary disease, patients with COVID-19 may also experience cardiac, hepatic, renal, and central nervous system disease. AIM OF THE STUDY;To describe the role and outcome, of high-dose of oral liposomal vitamin C treatment in reducing mortality in Covid-19 patients admitted in Government Medical College & ESI Hospital, Coimbatore, India. Materials and methods: Patients who admitted with the diagnosis of COVID-19 by RTPCR in government medical college and ESI hospital Coimbatore during 1 th march 2021 to may 31,2021 are taken for this retrospective study. Of the 8634 patients admitted 5422(62%) required non oxygen beds. -2989(34%) required oxygen beds on admission -223 patients(2.5%) required beds (with,98 on c pap, 34 ventilators,64 high flow nasal oxygen, 43 non re-breathing mask and 58 non invasive ventilators), all outcomes are compared with same type of patients admitted in similar hospital and similar set of patients, without high dose vitamin c.
Role of high dose oral liposomal vitamin -C in reducing mortality in patients with COVID-19